Largest health care companies — Page 6
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 501 | Scribe TherapeuticsSCTX | $293.7M | $15.52 | -7.54% | United States |
| 502 | Sanara MedTechSMTI | $290.6M | $31.63 | -2.18% | United States |
| 503 | AgenusAGEN | $290.4M | $6.43 | -7.75% | United States |
| 504 | Canopy GrowthCGC | $287.0M | $0.68 | -9.75% | Canada |
| 505 | Kyverna TherapeuticsKYTX | $284.8M | $4.61 | -10.76% | United States |
| 506 | Prelude TherapeuticsPRLD | $283.7M | $3.56 | -12.87% | United States |
| 507 | Fulcrum TherapeuticsFULC | $281.5M | $3.69 | -2.25% | United States |
| 508 | ClearPoint NeuroCLPT | $279.0M | $8.71 | -14.32% | United States |
| 509 | OcugenOCGN | $276.5M | $0.82 | -6.80% | United States |
| 510 | Precision BiosciencesDTIL | $274.7M | $9.84 | +21.12% | United States |
| 511 | VogenxVOGX | $273.8M | $18.43 | -6.59% | United States |
| 512 | Century TherapeuticsIPSC | $273.4M | $1.51 | -9.58% | United States |
| 513 | Turn TherapeuticsTTRX | $272.7M | $8.93 | -8.88% | United States |
| 514 | Treace Medical ConceptsTMCI | $269.6M | $4.15 | -7.89% | United States |
| 515 | InfuSystemINFU | $267.5M | $13.43 | +2.13% | United States |
| 516 | Rocket PharmaceuticalsRCKT | $267.3M | $2.44 | -6.71% | United States |
| 517 | Arcturus TherapeuticsARCT | $266.9M | $9.39 | -13.63% | Israel |
| 518 | SAB BiotherapeuticsSABS | $266.6M | $2.93 | -7.86% | United States |
| 519 | Cypherpunk TechnologiesCYPH | $265.6M | $2.47 | -14.11% | United States |
| 520 | Q32 BioQTTB | $265.1M | $8.86 | -1.23% | United States |
| 521 | ARS PharmaceuticalsSPRY | $263.0M | $2.65 | -13.28% | United States |
| 522 | EvommuneEVMN | $262.8M | $6.37 | +5.46% | United States |
| 523 | Anika TherapeuticsANIK | $259.2M | $19.37 | -5.05% | United States |
| 524 | Usana Health SciencesUSNA | $256.1M | $13.86 | -3.28% | United States |
| 525 | BioAge LabsBIOA | $254.3M | $5.54 | -6.89% | United States |
| 526 | Profound MedicalPROF | $251.6M | $6.89 | -3.81% | Canada |
| 527 | Lineage Cell TherapeuticsLCTX | $247.3M | $0.98 | -5.07% | United States |
| 528 | Larimar TherapeuticsLRMR | $244.6M | $2.36 | -14.67% | United States |
| 529 | Bicycle TherapeuticsBCYC | $243.9M | $3.48 | -6.47% | United Kingdom |
| 530 | Lifecore Biomedical, Inc. DeLFCR | $242.4M | $6.40 | -0.70% | United States |
| 531 | Lexeo TherapeuticsLXEO | $239.6M | $2.92 | -9.60% | United States |
| 532 | Amarin Corp PlcukAMRN | $238.3M | $11.55 | -5.71% | Ireland |
| 533 | Camp4 TherapeuticsCAMP | $233.4M | $3.72 | -0.54% | United States |
| 534 | Orasure TechnologiesOSUR | $232.8M | $3.38 | -9.27% | United States |
| 535 | Utah Medical ProductsUTMD | $226.4M | $71.10 | -1.82% | United States |
| 536 | Fate TherapeuticsFATE | $225.9M | $1.89 | -9.81% | United States |
| 537 | Abeona TherapeuticsABEO | $224.4M | $3.93 | -6.99% | United States |
| 538 | Nu Skin EnterprisesNUS | $221.7M | $4.56 | -8.72% | United States |
| 539 | ElectromedELMD | $221.4M | $26.72 | -4.62% | United States |
| 540 | Korro BioKRRO | $219.3M | $14.89 | -10.41% | United States |
| 541 | ImmuneeringIMRX | $217.9M | $3.37 | -10.51% | United States |
| 542 | Vanda PharmaceuticalsVNDA | $217.7M | $3.60 | -7.22% | United States |
| 543 | TriSalus Life SciencesTLSI | $217.4M | $3.53 | -9.25% | United States |
| 544 | Greenwich LifeSciencesGLSI | $214.6M | $14.62 | -10.58% | United States |
| 545 | Cabaletta BioCABA | $214.5M | $1.27 | -10.91% | United States |
| 546 | Siga TechnologiesSIGA | $213.0M | $2.97 | -5.87% | United States |
| 547 | AC ImmuneACIU | $212.7M | $2.09 | -8.73% | Switzerland |
| 548 | BiodesixBDSX | $211.0M | $20.00 | -6.93% | United States |
| 549 | ADC TherapeuticsADCT | $207.5M | $1.63 | -5.52% | Switzerland |
| 550 | Sol-Gel TechnologiesSLGL | $206.3M | $63.01 | -4.53% | Israel |
| 551 | Cartesian TherapeuticsRNAC | $205.2M | $6.78 | -0.57% | United States |
| 552 | Protalix BioTherapeuticsPLX | $202.6M | $2.52 | -6.51% | Israel |
| 553 | K2 Capital AcquisitionKTWO | $202.4M | $10.10 | +0.00% | Cayman Islands |
| 554 | Artiva BiotherapeuticsARTV | $202.4M | $4.14 | -1.90% | United States |
| 555 | Palisade BioPALI | $202.2M | $1.16 | -7.20% | United States |
| 556 | Inhibikase TherapeuticsIKT | $201.6M | $1.45 | -7.67% | United States |
| 557 | Bright Minds BiosciencesDRUG | $201.3M | $20.50 | +8.12% | Canada |
| 558 | Glass House BrandsGLAS | $200.6M | $2.28 | -11.63% | Unknown |
| 559 | Eledon PharmaceuticalsELDN | $199.9M | $2.46 | -8.89% | United States |
| 560 | InflaRxIFRX | $198.9M | $1.35 | -8.78% | Germany |
| 561 | Pro DexPDEX | $195.6M | $61.13 | -3.64% | United States |
| 562 | Pyxis OncologyPYXS | $193.1M | $1.62 | -2.71% | United States |
| 563 | Edap TmsFOCL | $192.5M | $4.19 | -3.01% | France |
| 564 | RxSightRXST | $189.7M | $4.53 | -9.32% | United States |
| 565 | NeuroneticsSTIM | $188.5M | $2.43 | -10.35% | United States |
| 566 | ProQR TherapeuticsPRQR | $188.4M | $1.34 | -5.32% | Netherlands |
| 567 | Keros TherapeuticsKROS | $187.6M | $9.46 | -12.65% | United States |
| 568 | CompugenCGEN | $183.0M | $1.94 | -4.68% | Israel |
| 569 | ExagenXGN | $181.4M | $7.49 | -11.99% | United States |
| 570 | InogenINGN | $181.3M | $6.83 | -5.40% | United States |
| 571 | Entrada TherapeuticsTRDA | $176.8M | $4.54 | -10.28% | United States |
| 572 | Natures Sunshine ProductsNATR | $176.6M | $10.19 | -20.64% | United States |
| 573 | Upstream BioUPB | $175.8M | $3.21 | -13.24% | United States |
| 574 | BridgeBio Oncology TherapeuticsBBOT | $175.2M | $2.19 | -5.00% | United States |
| 575 | MediWoundMDWD | $174.9M | $13.44 | -5.35% | Israel |
| 576 | Whitehawk TherapeuticsWHWK | $173.9M | $3.05 | -3.79% | United States |
| 577 | InvivydIVVD | $171.6M | $0.58 | -8.10% | United States |
| 578 | Niagen BioscienceNAGE | $166.3M | $2.10 | -16.67% | United States |
| 579 | Zentalis PharmaceuticalsZNTL | $162.8M | $1.72 | -2.27% | United States |
| 580 | Oramed PharmaceuticalsORMP | $162.6M | $3.91 | -5.33% | Israel |
| 581 | PepGenPEPG | $160.3M | $2.32 | -5.51% | United States |
| 582 | Innate PharmaIPHA | $156.4M | $1.40 | +0.71% | France |
| 583 | Canton StrategicCNTN | $152.6M | $1.92 | -11.34% | United States |
| 584 | Sutro BiopharmaSTRO | $152.0M | $9.17 | -7.80% | United States |
| 585 | Inovio PharmaceuticalsINO | $150.4M | $1.46 | -10.19% | United States |
| 586 | AN2 TherapeuticsANTX | $149.8M | $3.97 | -6.59% | United States |
| 587 | Sionna TherapeuticsSION | $147.8M | $3.27 | -12.33% | United States |
| 588 | Atrium TherapeuticsRNA | $143.5M | $8.39 | -3.34% | United States |
| 589 | MacrogenicsMGNX | $143.3M | $2.25 | -2.60% | United States |
| 590 | Alx OncologyALXO | $143.0M | $1.15 | -15.81% | United States |
| 591 | Nervgen PharmaNGEN | $141.0M | $1.31 | -2.96% | Canada |
| 592 | KORU Medical SystemsKRMD | $139.9M | $3.03 | -7.34% | United States |
| 593 | Veraxa Biotech AG - Post de-SPACVRXA | $139.4M | $0.99 | +3.80% | Switzerland |
| 594 | Burning Rock BiotechBNR | $139.2M | $13.20 | +2.88% | China |
| 595 | Satellos BioscienceMSLE | $135.8M | $6.40 | -1.08% | Canada |
| 596 | MaxcyteMXCT | $135.2M | $1.31 | -5.75% | United States |
| 597 | AdageneADAG | $133.4M | $2.02 | -16.18% | China |
| 598 | Organigram GlobalOGI | $132.3M | $0.94 | -2.79% | Canada |
| 599 | Jyong BiotechMENS | $129.2M | $1.70 | -2.30% | Taiwan |
| 600 | Cue BiopharmaCUE | $128.9M | $17.75 | -10.56% | United States |
Showing 501–600 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.